Yahoo
NYSE American - Delayed Quote USD

Apimeds Pharmaceuticals US, Inc. (APUS)

3.0100 -0.2000 (-6.23%)
At close: October 30 at 4:00:00 PM EDT
2.8799 -0.1301 (-4.32%)
After hours: October 30 at 5:38:16 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
27,348.7440
11,912.5620
1,275.0950
747.4360
639.5290
Operating Income
-27,348.7440
-11,912.5620
-1,275.0950
-747.4360
-639.5290
Net Non Operating Interest Income Expense
-4,190.9690
-175.4160
-114.8950
-30.2580
-29.1370
Other Income Expense
-26,629.8160
6,086.8410
--
--
--
Pretax Income
-58,169.5290
-6,001.1370
-1,389.9900
-777.6940
-668.6660
Net Income Common Stockholders
-58,169.5290
-6,001.1370
-1,389.9900
-777.6940
-668.6660
Diluted NI Available to Com Stockholders
-58,169.5290
-6,001.1370
-1,389.9900
-777.6940
-668.6660
Basic EPS
-35.98
-5.50
-1.20
-0.67
-0.58
Diluted EPS
-35.98
-5.50
-1.20
-0.67
-0.58
Basic Average Shares
1,447.0900
1,088.1900
1,157.1490
1,157.1490
1,157.1490
Diluted Average Shares
1,447.0900
1,088.1900
1,157.1490
1,157.1490
1,157.1490
Total Operating Income as Reported
-27,348.7440
-11,912.5620
-1,275.0950
-747.4360
-639.5290
Total Expenses
27,348.7440
11,912.5620
1,275.0950
747.4360
639.5290
Net Income from Continuing & Discontinued Operation
-58,169.5290
-6,001.1370
-1,389.9900
-777.6940
-668.6660
Normalized Income
-30,971.8660
-12,087.8810
-1,389.9900
-777.6940
-668.6660
Interest Income
114.1160
107.5950
2.8240
7.8110
0
Interest Expense
4,305.0850
283.0110
117.7190
38.0690
29.1370
Net Interest Income
-4,190.9690
-175.4160
-114.8950
-30.2580
-29.1370
EBIT
-53,864.4440
-5,718.1260
-1,272.2710
-739.6250
-639.5290
EBITDA
-53,818.6460
-5,712.4200
-1,272.2710
-739.6250
-639.5290
Reconciled Depreciation
45.7980
5.7060
0
--
--
Net Income from Continuing Operation Net Minority Interest
-58,169.5290
-6,001.1370
-1,389.9900
-777.6940
-668.6660
Total Unusual Items Excluding Goodwill
-27,197.6630
6,086.7440
--
--
--
Total Unusual Items
-27,197.6630
6,086.7440
--
--
--
Normalized EBITDA
-26,620.9830
-11,799.1640
-1,272.2710
-739.6250
-639.5290
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 5/9/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: